Global Gut Microbiome Growth Opportunities

Global Gut Microbiome Growth Opportunities Market - Growth Opportunities, Analysis, Forecast, Global, 2023

Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape - Microbiome Therapeutics,Human Microbiome,Microbiome Therapy

RELEASE DATE
07-Mar-2023
REGION
Global
Deliverable Type
Technology Research
Research Code: DA9A-01-00-00-00
SKU: HC03643-GL-TR_27488
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC03643-GL-TR_27488

Global Gut Microbiome Growth Opportunities
Published on: 07-Mar-2023 | SKU: HC03643-GL-TR_27488

Need more details?
$4,950.00
Need more details?

This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untargeted approaches, such as fecal microbiome therapy (FMT), probiotics, prebiotics, and synbiotics. However, technological advancements have resulted in the development of and demand for targeted interventions for microbiome therapeutics. Emerging technologies in this space include targeted drugs, cultured commensals, bio-engineered commensals, and bacteriophage therapies. There has been an increase in investments and government funding for the development of gut microbiome therapeutics. The market for gut microbiome therapeutics is expected to see significant growth over the next five years.

Key Questions this Study will Answer:
1. What are the factors driving and restraining the development of gut microbiome therapeutics?
2. What are the venture funding and patent landscapes like for gut microbiome therapeutics?
3. Who are the key industry participants developing gut microbiome therapeutics?
4. What are the clinical trends emerging across each targeted and untargeted approach for the development of gut microbiome therapeutics?
5. What are the key growth opportunities emerging from the shifts in this space? How should market players and stakeholders leverage these opportunities?

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Gut Microbiome Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Introduction

Growth Drivers

Growth Driver Analysis

Growth Restraints

Growth Restraints Analysis

Scope of Analysis

Segmentation

Research Methodology

Regulatory Landscape for Microbiome in Europe

Regulatory Landscape for Microbiome in Europe (continued)

Regulatory Landscape for Microbiome across the Asia-Pacific

Regulatory Landscape for Microbiome across the Asia-Pacific (continued)

Regulatory Landscape for Microbiome in North America

Summary of Global Probiotic Regulations

Untargeted Approaches for Treating Oncology Conditions

Untargeted Approaches for Treating Gastrointestinal Conditions

Untargeted Approaches for Treating Metabolic Conditions

Untargeted Approaches for Treating Neurological Conditions

Untargeted Approaches for Treating Other Conditions

Analyst Insight—Untargeted Approaches

Targeted Approaches for Treating Oncology Conditions

Targeted Approaches for Treating Gastrointestinal Conditions

Targeted Approaches for Treating Neurological Conditions

Targeted Approaches for Treating Other Conditions

Analyst Insights—Targeted Approach

Analyst Insights—Targeted Approach (continued)

Innovation Spotlight in Untargeted Approach

Innovation Spotlight in Targeted Approach

Innovation Spotlight in Targeted Approach (continued)

R&D Activities (Basic/Applied and Exploratory Research)

Research Landscape: Analyst Insights

Research Landscape: Analyst Insights (continued)

Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics

Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics (continued)

Increasing Collaborations and Partnerships to Promote the Development of Gut Microbiome Therapeutics (continued)

Patent Landscape for Microbiome Industry

Patent Landscape for Microbiome Industry (continued)

Significant Venture Capital and Private Equity Funding Boost Innovations in the Gut Microbiome Industry

Government Grant Funding Supporting Innovations in the Gut Microbiome Industry

Growth Opportunity 1: Gut Microbiome Targeted Approaches

Growth Opportunity 1: Gut Microbiome Targeted Approaches (continued)

Growth Opportunity 2: Gut-Brain Axis Applications

Growth Opportunity 2: Gut-Brain Axis Applications (continued)

Growth Opportunity 3: Oncological Applications

Growth Opportunity 3: Oncological Applications (continued)

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study identifies and analyzes research initiatives focused on the development of gut microbiome therapeutics. Disruption of the gut microbiome causes a range of health issues, including gastrointestinal diseases, immuno-oncological diseases, and metabolic diseases. Over the last decade, gut microbiome therapeutics have largely relied on untargeted approaches, such as fecal microbiome therapy (FMT), probiotics, prebiotics, and synbiotics. However, technological advancements have resulted in the development of and demand for targeted interventions for microbiome therapeutics. Emerging technologies in this space include targeted drugs, cultured commensals, bio-engineered commensals, and bacteriophage therapies. There has been an increase in investments and government funding for the development of gut microbiome therapeutics. The market for gut microbiome therapeutics is expected to see significant growth over the next five years. Key Questions this Study will Answer: 1. What are the factors driving and restraining the development of gut microbiome therapeutics 2. What are the venture funding and patent landscapes like for gut microbiome therapeutics 3. Who are the key industry participants developing gut microbiome therapeutics 4. What are the clinical trends emerging across each targeted and untargeted approach for the development of gut microbiome therapeutics 5. What are the key growth opportunities emerging from the shifts in this space How should market players and stakeholders leverage these opportunities
More Information
New Title Global Gut Microbiome Growth Opportunities Market - Growth Opportunities, Analysis, Forecast, Global, 2023
New Subtitle Targeted Gut Microbiome Technologies to Drive Transformational Growth Across the Global Healthcare Landscape - Microbiome Therapeutics,Human Microbiome,Microbiome Therapy
Deliverable Type Technology Research
Author Priyanka Jain
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Microbiome Therapeutics
Keyword 2 Microbiome Therapy
Keyword 3 Human Microbiome
Podcast No
WIP Number DA9A-01-00-00-00